Drug Type Contrast agent, Small molecule drug |
Synonyms- |
Target- |
Mechanism Magnetic resonance imaging enhancers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Iron-Deficiency | Phase 2 | US | 29 Nov 2018 |